184 related articles for article (PubMed ID: 30693819)
21. Silica-based nanosystems for therapeutic applications in the skin.
Arriagada F; Nonell S; Morales J
Nanomedicine (Lond); 2019 Aug; 14(16):2243-2267. PubMed ID: 31411537
[TBL] [Abstract][Full Text] [Related]
22. In vivo wound healing performance of drug loaded electrospun composite nanofibers transdermal patch.
Kataria K; Gupta A; Rath G; Mathur RB; Dhakate SR
Int J Pharm; 2014 Jul; 469(1):102-10. PubMed ID: 24751731
[TBL] [Abstract][Full Text] [Related]
23. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
24. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
Al-Lawati H; Binkhathlan Z; Lavasanifar A
Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
[TBL] [Abstract][Full Text] [Related]
25. The importance of reflecting on treatment and post-treatment care when assessing the social aspects of cosmetic nanomedicine and transdermal delivery system.
Duché G; Thordarson P; Kearnes M
Nanomedicine; 2020 Aug; 28():102214. PubMed ID: 32360550
[TBL] [Abstract][Full Text] [Related]
26. The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems.
Haddish-Berhane N; Rickus JL; Haghighi K
Int J Nanomedicine; 2007; 2(3):315-31. PubMed ID: 18019831
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
[TBL] [Abstract][Full Text] [Related]
28. Second world conference on nanomedicine and drug delivery.
Ninan N; Thomas S; George A; Sebastian M
Ther Deliv; 2011 Jun; 2(6):711-5. PubMed ID: 22822503
[TBL] [Abstract][Full Text] [Related]
29. Nanomedical engineering: shaping future nanomedicines.
Luo D; Carter KA; Lovell JF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
[TBL] [Abstract][Full Text] [Related]
30. Targeted Nanotechnology from Bench to Bedside.
Sapalidis K; Kosmidis C; Laskou S; Katsaounis A; Mantalobas S; Passos I; Michalopoulos N; Amaniti A; Sardeli C; Zarogoulidis P
Curr Cancer Drug Targets; 2019; 19(1):3-4. PubMed ID: 30672409
[No Abstract] [Full Text] [Related]
31. Novel preparation of transdermal drug-delivery patches and functional wound healing materials.
Ahmad Z; Stride E; Edirisinghe M
J Drug Target; 2009 Nov; 17(9):724-9. PubMed ID: 19845489
[TBL] [Abstract][Full Text] [Related]
32. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems.
Keck CM; Müller RH
Eur J Pharm Biopharm; 2013 Aug; 84(3):445-8. PubMed ID: 23333302
[TBL] [Abstract][Full Text] [Related]
33. Nanotechnology based therapeutics for lung disease.
Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
[TBL] [Abstract][Full Text] [Related]
34. Functionalized magnetic nanoparticles for biomedical applications.
Gudovan D; Balaure PC; Mihăiescu DE; Fudulu A; Purcăreanu B; Radu M
Curr Pharm Des; 2015; 21(42):6038-54. PubMed ID: 26503153
[TBL] [Abstract][Full Text] [Related]
35. Quality-by-design of nanopharmaceuticals - a state of the art.
Bastogne T
Nanomedicine; 2017 Oct; 13(7):2151-2157. PubMed ID: 28579437
[TBL] [Abstract][Full Text] [Related]
36. Microscale oral delivery devices incorporating nanoparticles.
Phua K; Leong KW
Nanomedicine (Lond); 2010 Feb; 5(2):161-3. PubMed ID: 20148626
[No Abstract] [Full Text] [Related]
37. Nanomedicine: a matter of rhetoric?
Nat Mater; 2006 Apr; 5(4):243. PubMed ID: 16582920
[No Abstract] [Full Text] [Related]
38. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
[TBL] [Abstract][Full Text] [Related]
39. Welcome to the 14th volume of Nanomedicine.
Chard L
Nanomedicine (Lond); 2019 Jan; 14(1):1-4. PubMed ID: 30548078
[No Abstract] [Full Text] [Related]
40. A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α.
Tang T; Jiang H; Yu Y; He F; Ji SZ; Liu YY; Wang ZS; Xiao SC; Tang C; Wang GY; Xia ZF
Int J Nanomedicine; 2015; 10():6571-85. PubMed ID: 26527874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
